As a subsidiary of Sumitomo Corporation, Oxford provides access to the Japanese marketplace. We introduce our clients to Sumitomo resources that will assist with:     Drug and diagnostics licensing     Research and development collaborations for pharmaceuticals and medical devices     Equity investments